Achyut Healthcare Intrinsic Value
Achyut Healthcare (ACHYUT) median intrinsic value is ₹2.13 from 6 valuation models (range ₹2–₹18), vs current price ₹7.10 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse ACHYUT FII DII holdings to track promoter, FII and institutional holdings.
ACHYUT Valuation Methods Summary — DCF, Graham Number & P/E
Achyut Healthcare intrinsic value across 6 models vs current price ₹7.10 — upside/downside and value range per method. Read ACHYUT dividend yield for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.13 | ₹1.70 - ₹2.56 | -70.0% | EPS: ₹0.01, Sector P/E: 22x |
| Book Value Method | asset | ₹17.75 | ₹15.97 - ₹19.53 | +150.0% | Book Value/Share: ₹14.58, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹10.00 | ₹9.00 - ₹11.00 | +40.8% | Revenue/Share: ₹5.00, P/S: 2.0x |
| PEG Ratio Method | growth | ₹2.13 | ₹1.92 - ₹2.34 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹2.13 | ₹1.92 - ₹2.34 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 16.1x |
| Graham Defensive Method | conservative | ₹2.13 | ₹1.92 - ₹2.34 | -70.0% | EPS: ₹0.01, BVPS: ₹14.58 |
ACHYUT Intrinsic Value vs Market Price — All Valuation Models
Achyut Healthcare fair value range ₹2–₹18 vs current market price ₹7.10 across 6 valuation models. For current market price and key ratios, visit ACHYUT screener.
ACHYUT Intrinsic Value Analysis — Undervalued or Overvalued?
Achyut Healthcare median intrinsic value ₹2.13, current price ₹7.10 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of ACHYUT?
Based on our comprehensive analysis using 6 different valuation methods, the estimated intrinsic value of Achyut Healthcare (ACHYUT) is ₹2.13 (median value). With the current market price of ₹7.10, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹2.13 to ₹17.75, indicating ₹2.13 - ₹17.75.
Is ACHYUT undervalued or overvalued?
Based on our multi-method analysis, Achyut Healthcare (ACHYUT) appears to be trading above calculated value by approximately 70.0%.
ACHYUT Financial Health — Key Ratios vs Industry Benchmarks
Achyut Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 8.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.32x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ACHYUT Cash Flow Quality — Operating & Free Cash Flow
Achyut Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-7 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |